Neuropathological and neurolasychological changes in 'normal' aging: Evidence for preclinical Alzheimer Disease in cognitively normal individuals

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 12, 1998, Pages 1168-1174

  Hulette, Christine M ^a   Welsh Bohmer, Kathleen A ^a   Murray, Michael G ^a   Saunders, Ann M ^a   Mash, Deborah C ^a,b   McIntyre, Lauren M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Neuropathology; Neuropsychology; Normal aging

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE; CASE CONTROL STUDY; COGNITION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REFERENCE VALUE; REGISTER;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; REGISTRIES;

EID: 0031593785     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199812000-00009     Document Type: Article

References (29)

1. Mrak RE, Griffin WST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997;56:1269-75
2. Delaere P, He Y, Fayet G et al. βA4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 French centenarians. Neurobiol Aging 1993;14:191-94
3. Delaere P, Duyckaerts C, Masters C, Beyreuther K, Piette F. Hauw J-J. Large amounts of neocortical bA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 1990;116:87-93
4. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's Disease. Neurology of Aging 1991;12:295-312
5. Dickson D, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1991;13:179-89
6. Hyman BT Anatomy of pathological alterations in Alzheimer's Disease. In Molecular Mechanisms of Dementia. Humana Press, Totowa, New Jersey. Wasco W, Tanzi RE (eds.) 1997:219-23
7. Morris JC, Storandt M, McKeel DW, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurol 1996;46: 707-19
8. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N Eng J Med 1996;334:752-58
9. Tagliavini F, Giaccone G, Frangione B, Bugiani O. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 1988;93:191-96
10. Welsh KA, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278-81
11. Welsh KA, Butters N, Hughes J, et al. Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992;49:448-52
12. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences - National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations in twin concordance. Arch Neurol 1995; 52:763-71
13. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurol 1993;43:1467-72
14. Saunders AM, Hulette C, Welsh-Bohmer, KA et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93
15. Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The consortium to establish a registry for Alzheimer's disease (CERAD). Part X. Neurol 1995;45:461-66
16. Mirra SS, Heyman A, McKeel et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurol 1991;41:479-86
17. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
18. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. Rapid brain autopsy: The Bryan Alzheimer's Disease Research Center Experience. Arch Path Lab Med 1997; 121:615-18.
19. Folstein MF, Folstein SE. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-98
20. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurol 1995;45:957-62
21. Koss E, Edland S, Fillenbaum G, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, part XII. Neurol 1996; 46:136-41
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurol 1984;34:939-44
23. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I: Clinical and Neuropsychological assessment of Alzheimer's disease. Neurol 1989;39: 1159-65
24. Steffens DC, Welsh KA, Burke JR. et al. Diagnosis of Alzheimer's disease in epidemiological studies by staged review of clinical data. Neuropsychiatry Neuropsychol Behav Neurol 1996;9:107-13
25. Troster AI, Butters N, Salmon DP, et al. The diagnostic utility of savings scores: Differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests. J Clin Exp Neurol 1993;15:773-88
26. Welsh KA, Butters N, Mohs RC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part V - A normative study of the neuropsychological battery. Neurol 1994;44:609-14
27. Wisniewski HM, Robe A, Zigman W, Silverman W. Neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 1989;48:606-609
28. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer's disease. FEBS Lett 1994;344:69-73
29. Welsh-Bohmer KA, Mohs RC. Neuropsychological assessment of Alzheimer's disease. Neurol 1997;49:S11-S13